Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Nadia Lobello, Flavia Biamonte, Maria Elena Pisanu, Maria Concetta Faniello, Žiga Jakopin, Emanuela Chiarella, Emilia Dora Giovannone, Rita Mancini, Gennaro Ciliberto, Giovanni Cuda, Francesco Costanzo
Published Aug 22, 2016 · Vol. 7, No. 38 · pp. 62019-62033
Michael J. Overman, Van Morris, Helen Moinova, Ganiraju Manyam, Joe Ensor, Michael S. Lee, Cathy Eng, Bryan Kee, David Fogelman, Rachna T. Shroff, Thomas LaFramboise, Thibault Mazard, Tian Feng, Stanley Hamilton, Bradley Broom, James Lutterbaugh, Jean-Pierre Issa, Sanford D. Markowitz, Scott Kopetz
Published Aug 16, 2016 · Vol. 7, No. 41 · pp. 67495-67506
Dubravka Å kalamera, Mareike Dahmer-Heath, Alexander J. Stevenson, Cletus Pinto, Esha T. Shah, Sheena M. Daignault, Nur Akmarina B.M. Said, Melissa Davis, Nikolas K. Haass, Elizabeth D. Williams, Brett G. Hollier, Erik W. Thompson, Brian Gabrielli, Thomas J. Gonda
Published Aug 16, 2016 · Vol. 7, No. 38 · pp. 61000-61020